There may be over 34 million adult smokers in the US, but nearly 70% of those people are trying to kick the habit. Unfortunately, only a handful are ever successful, regardless if they try to quit cold turkey or by using one of the many smoking cessation therapies on the market.
Luckily, another potential smoking cessation therapy is available for the 23 million people who want to quit and could be more effective than other methods.
Cannabidiol (CBD) has been shown to help with chronic pain, anxiety, and rare forms of epilepsy, and is now also being studied for its effectiveness as a quit smoking aid.
Sativa Group Plc (NEX:SATI) is the UK’s leading quoted CBD Wellness and medicinal cannabis group with five operating subsidiaries. Goodbody Botanicals provides CBD products online and to retail markets including pharmacies, wellness stores and grocers. Goodbody Wellness is a high-street retail brand with dedicated CBD Wellness stores providing a premium shopping experience to consumers. Tessellate Collective is a direct-selling network marketing platform servicing consumers at home. Phytovista laboratories provides independent testing of CBD products to both external customers and fellow Group businesses. Sativa Grow holds a Controlled Drug licence and cultivates cannabis plants to fulfill its partnership agreement with King’s College London to research the impact of cannabinoids on inflammation and respiratory conditions.